“Brain Metastases Pipeline Insight, 2023” report by DelveInsight outlines a comprehensive assessment of the present clinical/non-clinical development activities and growth prospects across the Brain Metastases Market.
The Brain Metastases Pipeline report embraces in-depth commercial, regulatory, and Brain Metastases clinical trial assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the emerging Brain Metastases drugs, including the mechanism of action, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.
Brain Metastases Pipeline Analysis
The report provides insights into:
-
The report provides detailed insights into the emerging therapies for Brain Metastases treatment and the aggregate therapies developed by major pharma companies.
-
It accesses the different Brain Metastases therapies segmented into early-stage, mid-stage, and late-stage of clinical development.
-
It outlines the major Brain Metastases companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
-
The report evaluates the Brain Metastases drugs that are under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
-
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and regulatory approval in the Brain Metastases therapeutic market.
The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Analysis of Emerging Brain Metastases Therapies by Phases
The report covers the emerging products under different phases of clinical development like –
-
Late-stage products (Phase III)
-
Mid-stage products (Phase II)
-
Early-stage product (Phase I)
-
Pre-clinical and Discovery stage candidates
-
Discontinued & Inactive candidates
Route of Administration
Brain metastases pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
-
Intra-articular
-
Intraocular
-
Intrathecal
-
Intravenous
-
Ophthalmic
-
Oral
-
Parenteral
-
Subcutaneous
-
Topical
-
Transdermal
Molecule Type
Products have been categorized under various Molecule types such as
-
Oligonucleotide
-
Peptide
-
Small molecule
Learn How the Brain Metastases Treatment Outlook will Evolve with the Ongoing Clinical & Commercial Activities in the Therapeutic Market @
https://www.delveinsight.com/sample-request/brain-metastases-pipeline-insight
Brain Metastases Companies Actively Working in the Therapeutic Market Include:
-
HUYA Bioscience International, LLC
-
Angiochem
-
Cantex Pharmaceuticals, Inc.
-
Bristol-Myers Squibb
-
ImmunoChem Therapeutics, LLC
-
Kazia Therapeutics
-
Alpha Biopharma Ltd
-
Betta Pharmaceuticals Co., Ltd.
-
TYK Medicines, Inc
-
BioMimetix JV, LLC
-
Amgen
-
Jubilant Therapeutics
-
Quadriga Biosciences, Inc.
-
Pfizer
-
Medolution Ltd.
-
Puma Biotechnology, Inc.
-
Seagen Inc.
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.
-
ABM Therapeutics Corporation
And Many Others
Emerging and Marketed Brain Metastases Drugs Covered in the Report Include:
-
HBI-8000: HUYA Bioscience
-
ANG1005: Angiochem Inc
-
Paxalisib: Kazia Therapeutics
-
TY-9591: TYK Medicines
-
BMX-001: BioMimetix
-
AMG 510: Amgen
-
RRx-001: EpicentRx, Inc.
-
JBI-778: Jubilant Therapeutics
-
SONALA-001: SonALAsense
-
LP-184: Lantern Pharma
And Many More
Request the Sample PDF to Get a Better Understanding of the Emerging Drugs and Brain Metastases Companies Working in the Market @
https://www.delveinsight.com/sample-request/brain-metastases-pipeline-insight
Table of Content (TOC)
1. Report Introduction
2. Executive Summary
3. Brain Metastases Treatment Patterns
4. Brain Metastases – DelveInsight’s Analytical Perspective
5. Therapeutic Assessment
6. Brain Metastases Late Stage Products (Phase-III)
7. Brain Metastases Mid-Stage Products (Phase-II)
8. Brain Metastases Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Brain Metastases Discontinued Products
13. Brain Metastases Product Profiles
14. Major Brain Metastases Companies in the Market
15. Key Products in the Brain Metastases Therapeutics Segment
16. Dormant and Discontinued Products
17. Brain Metastases Unmet Needs
18. Brain Metastases Future Perspectives
19. Brain Metastases Analyst Review
20. Appendix
21. Report Methodology
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF to Explore the Key Offerings of the Report @
https://www.delveinsight.com/sample-request/brain-metastases-pipeline-insight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Other Trending Healthcare Reports By DelveInsight
“Acute Pyelonephritis Market Insights, Epidemiology, and Market Forecast-2032” report deliver an in-depth understanding of the historical and forecasted epidemiology as well as the Acute Pyelonephritis market size, share, trends, and growth analysis in the seven major markets (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. Moreover, it also covers the current treatment practices, emerging drugs, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Acute Pyelonephritis market.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/